Q64-32381-88080
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 841 / UT
- Registered
- 2022-07-06
- Relationship
- Child or adolescent in my care
- Guardian
- 9YH-29950-16632
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-29
Dose 1 — Pfizer-BioNTech
-
2022-07-06
Registered in v-safe
- 2022-07-06
- 2022-07-13
- 2022-07-20
-
2022-07-27
Dose 2 — Pfizer-BioNTechCo-administered: Hepatitis A
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-07-31
- 2022-08-01
- 2022-08-02
- 2022-08-03
-
2022-08-10
Survey response — day 14, dose 2, under 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Stuffy/runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-08-17
- 2022-08-24
- 2022-08-31
-
2022-09-09
Survey response — day 42, dose 2, under 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Congestion, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-27
- 2023-01-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-29 | Pfizer-BioNTech | No |
| 2 | 2022-07-27 | Pfizer-BioNTech | Hepatitis A |
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Stuffy/runny nose
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Congestion, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release